Category Archives: Hatch-Waxman

Supreme Court Grants Cert. In Caraco

Today (June 27, 2010), the Supreme Court granted cert. in yet another patent appeal, Caraco Pharm. Labs., Ltd., v. Novo Nordisk, (Supreme Ct. 10-844). Earlier this month, I did an extensive post on the decision below, in which the Fed. … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , | Leave a comment

Caraco – The Little Counterclaim That Could?

I normally try to steer clear of issues raised in Hatch-Waxman litigation between the “innovators” and the “generics,” unless it raises specific points of patent law of general interest – there is just so much of it, and other blogs … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , , , | 2 Comments

Astrazeneca v Apotex – Patent That Label!

I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , | 1 Comment

Paragraph IV Patent Certifications

For your reference here is a link to the FDA Paragraph IV Patent Certifications as well as a PDF of the certifications. FDA Paragraph IV Patent Certifications Paragraph IV Patent Certifications.pdf

Posted in Hatch-Waxman | Tagged , , | 1 Comment